Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (62)

1

Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study

enthalten in: Bone marrow transplantation | 2015

von Nikolousis, E. | Nagra, S. | Pearce, R. | +13

2

Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation

enthalten in: Bone marrow transplantation | 2015

von Shaw, B. | Lee, F. | Krishnamurthy, S. | +8

3

Selective, efficient modulation of activated CD4+ αβT cells by the novel humanized antibody GZ-αβTCR targeting human αβTCR

enthalten in: Bone marrow transplantation | 2015

von Blank, G. | Welker, C. | Haarer, J. | +10

4

Chimerism does not predict for outcome after alemtuzumab-based conditioning : lineage-specific analysis of chimerism of specific diseases may be more informative

enthalten in: Bone marrow transplantation | 2008

von Lim, Z. | Pearce, L. | Ingram, W. | +3

CommentOn: Bone Marrow Transplant. 2007 Jul;40(2):181. - PMID 17502895

5

Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation

enthalten in: Bone marrow transplantation | 2008

von Penack, O. | Fischer, L. | Stroux, A. | +9

6

Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease : a single centre experience with 12 allograft patients

enthalten in: Bone marrow transplantation | 2008

von Hui, C. | Sia, H. | Mangos, H. | +6

7

Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen

enthalten in: Bone marrow transplantation | 2008

von Hansen, M. | Filipovich, A. | Davies, S. | +6

8

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation

enthalten in: Bone marrow transplantation | 2007

von Pollyea, D. | Artz, A. | Stock, W. | +10

9

Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan

enthalten in: Bone marrow transplantation | 2007

von Amarasinghe, K. | Dalley, C. | Dokal, I. | +3

10

Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival

enthalten in: Bone marrow transplantation | 2007

von Lim, Z. | Ingram, W. | Brand, R. | +7

CommentIn: Bone Marrow Transplant. 2008 Feb;41(3):317. - PMID 17982492

1
2
3
4
5
6
7
Nächster »
[7]